Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Nov;21(11):1970-8.
doi: 10.1681/ASN.2010010125. Epub 2010 Oct 14.

Age, race, diabetes, blood pressure, and mortality among hemodialysis patients

Affiliations

Age, race, diabetes, blood pressure, and mortality among hemodialysis patients

Orrin B Myers et al. J Am Soc Nephrol. 2010 Nov.

Abstract

Observational studies involving hemodialysis patients suggest a U-shaped relationship between BP and mortality, but the majority of these studies followed large, heterogeneous cohorts. To examine whether age, race, and diabetes status affect the association between systolic BP (SBP; predialysis) and mortality, we studied a cohort of 16,283 incident hemodialysis patients. We constructed a series of multivariate proportional hazards models, adding age and BP to the analyses as cubic polynomial splines to model potential nonlinear relationships with mortality. Overall, low SBP associated with increased mortality, and the association was more pronounced among older patients and those with diabetes. Higher SBP associated with increased mortality among younger patients, regardless of race or diabetes status. We observed a survival advantage for black patients primarily among older patients. Diabetes associated with increased mortality mainly among older patients with low BP. In conclusion, the design of randomized clinical trials to identify optimal BP targets for patients with ESRD should take age and diabetes status into consideration.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Analysis of the combined association of predialysis SBP and DBP on mortality in incident HD patients reveals that mortality was greater at lower versus higher SBP. Model adjusted for age; gender; race; cause of ESRD; and time-varying serum albumin, hemoglobin, creatinine, dialysis dosage, and postdialysis weight. Referent: SBP = 140 mmHg, DBP = 80 mmHg.
Figure 2.
Figure 2.
Age interacts with BP so that (A) mortality among incident HD patients is highest for older patients with lower SBP. Only patients <40 years old have increased mortality risk with increasing SBP. (B) Mortality is highest for older patients with lower DBP. (C) Mortality risk and PP show higher mortality risk for older patients with low PP. Models adjusted for age; gender; race; cause of ESRD; and time-varying serum albumin, hemoglobin, creatinine, dialysis dosage, and postdialysis weight. Error bars are point-wise 95% CIs. Referent: SBP = 140 mmHg, DBP = 80 mmHg, PP = 73 mmHg.
Figure 3.
Figure 3.
Black incident HD patients have lower mortality risk than white patients across all SBP and DBP (A and B), and diabetic patients have increased mortality risk when SBP <140 mmHg (C and D). Models adjusted for age; gender; race; cause of ESRD; and time-varying serum albumin, hemoglobin, creatinine, dialysis dosage, and postdialysis weight. Error bars are point-wise 95% CIs. Referent: SBP = 140 mmHg, DBP = 80 mmHg.
Figure 4.
Figure 4.
A survival advantage for black versus white incident HD patients exists for patients over 40 years across all SBP but not for younger patients (A through C). Diabetic patients over age 40 with lower SBP (<140 mmHg) have increased mortality relative to nondiabetic patients (D through F). The relationships between SBP and mortality among younger diabetic versus nondiabetic patients are similar. Models adjusted for gender; race; cause of ESRD; and time-varying serum albumin, hemoglobin, creatinine, dialysis dosage, and postdialysis weight. Error bars are point-wise 95% CIs. Referent: SBP = 140 mmHg and age shown in each panel.

Comment in

References

    1. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA 213: 1143–1152, 1970 - PubMed
    1. Kannel WB: Blood pressure as a cardiovascular risk factor: Prevention and treatment. JAMA 275: 1571–1576, 1996 - PubMed
    1. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA 202: 1028–1034, 1967 - PubMed
    1. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, Levy D: Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 345: 1291–1297, 2001 - PubMed
    1. Rosendorff C, Black HR, Cannon CP, Gersh BJ, Gore J, Izzo JL, Jr, Kaplan NM, O'Connor CM, O'Gara PT, Oparil S: Treatment of hypertension in the prevention and management of ischemic heart disease: A scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation 115: 2761–2788, 2007 - PubMed

Publication types

MeSH terms